Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-18-053713)

Filing Details

Accession Number:: 0001144204-18-053713
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-10-12 21:50:16
Reporting Period:: 2018-10-12

Accepted Time:: 2018-10-12 21:50:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1540159	Stellar Biotechnologies Inc.	SBOT	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1621331	E. Daniel Morse	C/O Stellar Biotechnologies, Inc. 332 East Scott Street Port Hueneme CA 93041		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares, Without Par Value	Disposition	2018-10-12	7,047	$1.31	20,741	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The Issuer completed a 1-for-7 reverse share split of its common shares effective May 4, 2018. The amount stated reflects the post-split adjustment. Fractional shares resulting from the reverse share split were rounded to the nearest whole share.